From Research to GMP-Ready Cell Lines: Bridging the Development Gap, Upcoming Webinar Hosted by Xtalks

In this free webinar, gain insight into strategies for bridging the gap from research to GMP-compliant manufacturing. Attendees will learn how automation and consultancy can streamline cell line development workflows and ensure compliance. The featured speakers will share real-world case studies on regenerating cell lines under GMP requirements. Attendees will also learn best practices for scalable tools and robust documentation in clinical translation.

TORONTO, Sept. 30, 2025 /PRNewswire/ — Transitioning innovative cell-based therapies from research environments to GMP-compliant manufacturing presents recurring challenges—whether in academia or industry. Inconsistent documentation, manual workflows, and lack of early quality planning often delay or derail progress.

This session explores how expert consultancy and automation platforms can help bridge these gaps. The speakers will discuss real-world examples, including how one team navigated the complexities of regenerating a previously hand-picked cell line under GMP requirements.

Register for this webinar to learn how early adoption of scalable tools and good documentation practices can support faster, more reliable translation to the clinic.

Join Dr. Zoe Hewitt, Co-Founder and CEO, Regenerative Cell Therapy Consulting (Regen CTC) Limited; and Camilla Domeneghetti, Biology Manager, Advanced Instruments, LLC, for the live webinar on Tuesday, October 14, 2025, with Broadcast 1 — UK & Europe at 9am BST/10am CEST and Broadcast 2 — North America at 8am PDT/11am EDT.

For more information, or to register for this event, visit From Research to GMP-Ready Cell Lines: Bridging the Development Gap (Broadcast 1) or From Research to GMP-Ready Cell Lines: Bridging the Development Gap (Broadcast 2).

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit www.xtalks.com
For information about hosting a webinar visit www.xtalks.com/why-host-a-webinar/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: vkovacevic@xtalks.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/from-research-to-gmp-ready-cell-lines-bridging-the-development-gap-upcoming-webinar-hosted-by-xtalks-302570014.html

SOURCE Xtalks

Staff

Recent Posts

Lightera Advances Fiber-integrated Temperature Feedback for Safer Laser-based Medical Procedures

SAN FRANCISCO, Jan. 16, 2026 /PRNewswire/ -- BiOS - Hall D Booth #8430, Photonics West Hall…

16 hours ago

DiagnosTear Announces Interim Clinical Results Indicating High Efficiency from TeaRx(TM) Red Eye

Vancouver, British Columbia--(Newsfile Corp. - January 16, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE:…

21 hours ago

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

Toronto, Ontario--(Newsfile Corp. - January 16, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"…

22 hours ago

University of Phoenix and LinkedIn to host webinar on AI in nursing with skills and strategies for a new era of healthcare

January 22 virtual event "AI in Action: Skills and Strategies for a New Era of…

22 hours ago

Instinct Science Acquires ScribbleVet to Deliver the Next Generation of Intelligent-Native Veterinary Practice Management Software

The combination redefines PIMS by embedding AI, workflow, and clinical intelligence into a single system…

22 hours ago

Hemostemix Receives FDA Support for Its Basket Protocol Approach

Calgary, Alberta--(Newsfile Corp. - January 16, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE:…

1 day ago